Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMOFlipid for Myocardial Protection in Cardiac Valve Replacement Surgery
NCT04951791Unknown
- Sponsor
- Assiut University
- Start
- Aug 2021
- Primary completion
- Aug 2023
- Modality
- Lipid-based Nanoparticles
01
Overview
Randomised trial of SMOFlipid in ischemia-reperfusion injury (IRI) (2 arms), sponsored by Assiut University. Primary endpoints: Myocardium protection at 72 hours and Inflammatory response at 72 hours. Status: unknown.
02
Drugs
SMOFlipid
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT04951791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04951791.